
Adline Chem Lab Falls to 52-Week Low of Rs.7.6 Amidst Market Pressure
2025-12-03 11:15:32Adline Chem Lab has reached a new 52-week low of Rs.7.6, marking a significant decline in its stock price amid broader market fluctuations and sector-specific pressures. The stock’s recent performance highlights ongoing challenges within the Pharmaceuticals & Biotechnology sector, with the company’s shares underperforming both the sector and key market indices.
Read More
Adline Chem Lab Hits Upper Circuit Amidst Unprecedented Buying Interest
2025-12-03 10:40:14Adline Chem Lab Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and only buy orders queued on the exchange. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand amid a backdrop of recent price volatility and subdued sector performance.
Read More
Adline Chem Lab Faces Intense Selling Pressure Amid Consecutive Losses
2025-12-03 10:35:22Adline Chem Lab Ltd has encountered significant selling pressure, with the stock hitting a new 52-week low of Rs.7.6 today. The pharmaceutical and biotechnology company’s shares have experienced consecutive declines, reflecting distress selling and a lack of buyer interest in the current market environment.
Read More
Adline Chem Lab Falls to 52-Week Low of Rs.8 Amidst Market Pressure
2025-12-02 15:50:22Adline Chem Lab has reached a new 52-week low of Rs.8, marking a significant decline in its stock price amid broader market fluctuations and sector underperformance. The pharmaceutical and biotechnology company’s shares have experienced notable downward pressure, reflecting a challenging period for the stock.
Read More
Adline Chem Lab Stock Falls to 52-Week Low of Rs.8 Amidst Market Pressure
2025-12-02 15:50:21Adline Chem Lab, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.8, marking a significant decline in its stock price amid broader market fluctuations and company-specific factors.
Read More
Adline Chem Lab Sees Extraordinary Buying Interest Amid Upper Circuit Scenario
2025-12-02 11:16:32Adline Chem Lab Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market behaviour suggests a potential multi-day circuit scenario, reflecting intense demand despite recent price volatility and sector underperformance.
Read More
Adline Chem Lab Falls to 52-Week Low of Rs.8.4 Amidst Continued Downtrend
2025-11-28 15:41:35Adline Chem Lab, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.8.4, marking a significant decline in its stock price amid a sustained downward trend over recent sessions.
Read More
Adline Chem Lab Hits Upper Circuit Amidst Unprecedented Buying Interest
2025-11-28 15:35:09Adline Chem Lab Ltd has witnessed extraordinary buying momentum today, with the stock hitting its upper circuit and an exclusive queue of buy orders dominating the market. This rare scenario, marked by the absence of sellers, suggests the possibility of a sustained multi-day circuit, reflecting intense investor interest despite recent price pressures.
Read More
Adline Chem Lab Stock Falls to 52-Week Low of Rs.8.74 Amidst Market Rally
2025-11-27 10:43:55Adline Chem Lab has reached a new 52-week low of Rs.8.74 today, marking a significant decline in its stock price as it continues to underperform within the Pharmaceuticals & Biotechnology sector despite a broadly positive market environment.
Read MoreIntimation Of Receipt Of Approval For Reclassification Application Of Promoter Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
26-Nov-2025 | Source : BSEintimation of Receipt of Approval for Reclassification Application of Promoter Under Regulations 31A of SEBI (Listing Obligations and Desclosure Requirements) Regulations 2015.
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Nov-2025 | Source : BSENewspaper Publication for Financial Results of the Company for the quarter and half year ended 30th September 2025.
Board Meeting Outcome for Board Meeting Outcome For Unaudited Standalone Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2025
12-Nov-2025 | Source : BSEWe hereby inform you that the Board of Directors of the Company at its meeting held today has approved the Unaudited Standalone financial results of the Company for the quarter and half year ended on 30th September 2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






